Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,052 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and therapeutic aspects of allergic asthma in adolescents.
Lombardi C, Gani F, Landi M, Boner A, Canonica GW, Passalacqua G. Lombardi C, et al. Among authors: canonica gw. Pediatr Allergy Immunol. 2003 Dec;14(6):453-7. doi: 10.1046/j.0905-6157.2003.00080.x. Pediatr Allergy Immunol. 2003. PMID: 14675472
Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial.
Mosbech H, Deckelmann R, de Blay F, Pastorello EA, Trebas-Pietras E, Andres LP, Malcus I, Ljørring C, Canonica GW. Mosbech H, et al. Among authors: canonica gw. J Allergy Clin Immunol. 2014 Sep;134(3):568-575.e7. doi: 10.1016/j.jaci.2014.03.019. Epub 2014 May 3. J Allergy Clin Immunol. 2014. PMID: 24797423 Clinical Trial.
Mepolizumab treatment in patients with severe eosinophilic asthma.
Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators. Ortega HG, et al. N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199059 Free article. Clinical Trial.
Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months.
Riccio AM, Mauri P, De Ferrari L, Rossi R, Di Silvestre D, Benazzi L, Chiappori A, Dal Negro RW, Micheletto C, Canonica GW. Riccio AM, et al. Among authors: canonica gw. Clin Transl Allergy. 2017 Mar 9;7:6. doi: 10.1186/s13601-017-0143-1. eCollection 2017. Clin Transl Allergy. 2017. PMID: 28293414 Free PMC article.
1,052 results